Utilization of Healthy Volunteers in Oncology Drug Development in Japan: A 10-Year Analysis of Approved Anticancer Agents (2014-2024).

Morihisa K, Yoshitsugu H, Wakuda H, Uemura N

Open source

DOI
10.1111/cts.70626
Published
2026 Jun
Container
Clinical and translational science
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/cts.70626,
  title = {Utilization of Healthy Volunteers in Oncology Drug Development in Japan: A 10-Year Analysis of Approved Anticancer Agents (2014-2024).},
  author = {Morihisa K and Yoshitsugu H and Wakuda H and Uemura N},
  year = {2026},
  journal = {Clinical and translational science},
  doi = {10.1111/cts.70626},
  url = {https://doi.org/10.1111/cts.70626}
}

RIS

TY  - JOUR
TI  - Utilization of Healthy Volunteers in Oncology Drug Development in Japan: A 10-Year Analysis of Approved Anticancer Agents (2014-2024).
AU  - Morihisa K
AU  - Yoshitsugu H
AU  - Wakuda H
AU  - Uemura N
PY  - 2026
JO  - Clinical and translational science
DO  - 10.1111/cts.70626
UR  - https://doi.org/10.1111/cts.70626
ER  - 

APA

K, M., H, Y., H, W., & N, U. (2026). Utilization of Healthy Volunteers in Oncology Drug Development in Japan: A 10-Year Analysis of Approved Anticancer Agents (2014-2024).. Clinical and translational science. https://doi.org/10.1111/cts.70626

Source records